Please provide your email address to receive an email when new articles are posted on . In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic reactions in ...

Please provide your email address to receive an email when new articles are posted on . An FDA advisory committee voted in support of ARS Pharmaceuticals’ neffy nasal spray for anaphylaxis in adults ...

Tiotropium Respimat is an inhaled corticosteroid drug patients administer once daily through Boehringer Ingelheim’s Respimat inhaler. The FDA first approved the drug in 2015 for asthma patients age 12 ...

Yearly flu shots are especially important for kids with asthma as any virus can trigger an asthma attack. But in the not-too-distant future, these kids might be able to get a spritz instead of a jab, ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...

Children with asthma and recurrent wheezing who received the intranasal live attenuated influenza vaccine (LAIV) did not experience increased lower respiratory events (LREs) compared with children who ...